Therapies used to treat endometriosis include: Hormonal contraceptives. Birth control pills, patches and vaginal rings help control the hormones responsible for the buildup of endometrialtissue each month
The global Endometriosis Therapies market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Endometriosis Therapies volume and value at global level, regional level and company level. From a global perspective, this report represents overall Endometriosis Therapies market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Endometriosis Therapies in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Endometriosis Therapies manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
AbbVie
Eli Lilly
AstraZeneca
Bayer
Astellas Pharma
Meditrina Pharmaceuticals
Pfizer
Neurocrine Biosciences
Takeda Pharmaceutical
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Hormonal Contraceptives
Gonadotropin-releasing Hormone (Gn-RH) Agonists
Progestin Therapy
Aromatase Inhibitors
Segment by Application
Hospital
Clinic
Other
The global Endometriosis Therapies market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Endometriosis Therapies volume and value at global level, regional level and company level. From a global perspective, this report represents overall Endometriosis Therapies market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Endometriosis Therapies in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Endometriosis Therapies manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
AbbVie
Eli Lilly
AstraZeneca
Bayer
Astellas Pharma
Meditrina Pharmaceuticals
Pfizer
Neurocrine Biosciences
Takeda Pharmaceutical
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Hormonal Contraceptives
Gonadotropin-releasing Hormone (Gn-RH) Agonists
Progestin Therapy
Aromatase Inhibitors
Segment by Application
Hospital
Clinic
Other
Table of Contents
Executive Summary
1 Industry Overview of Endometriosis Therapies
1.1 Definition of Endometriosis Therapies
1.2 Endometriosis Therapies Segment by Type
1.2.1 Global Endometriosis Therapies Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Hormonal Contraceptives
1.2.3 Gonadotropin-releasing Hormone (Gn-RH) Agonists
1.2.4 Progestin Therapy
1.2.5 Aromatase Inhibitors
1.3 Endometriosis Therapies Segment by Applications
1.3.1 Global Endometriosis Therapies Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Endometriosis Therapies Overall Market
1.4.1 Global Endometriosis Therapies Revenue (2014-2025)
1.4.2 Global Endometriosis Therapies Production (2014-2025)
1.4.3 North America Endometriosis Therapies Status and Prospect (2014-2025)
1.4.4 Europe Endometriosis Therapies Status and Prospect (2014-2025)
1.4.5 China Endometriosis Therapies Status and Prospect (2014-2025)
1.4.6 Japan Endometriosis Therapies Status and Prospect (2014-2025)
1.4.7 Southeast Asia Endometriosis Therapies Status and Prospect (2014-2025)
1.4.8 India Endometriosis Therapies Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Endometriosis Therapies
2.3 Manufacturing Process Analysis of Endometriosis Therapies
2.4 Industry Chain Structure of Endometriosis Therapies
3 Development and Manufacturing Plants Analysis of Endometriosis Therapies
3.1 Capacity and Commercial Production Date
3.2 Global Endometriosis Therapies Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Endometriosis Therapies
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Endometriosis Therapies Production and Capacity Analysis
4.2 Endometriosis Therapies Revenue Analysis
4.3 Endometriosis Therapies Price Analysis
4.4 Market Concentration Degree
5 Endometriosis Therapies Regional Market Analysis
5.1 Endometriosis Therapies Production by Regions
5.1.1 Global Endometriosis Therapies Production by Regions
5.1.2 Global Endometriosis Therapies Revenue by Regions
5.2 Endometriosis Therapies Consumption by Regions
5.3 North America Endometriosis Therapies Market Analysis
5.3.1 North America Endometriosis Therapies Production
5.3.2 North America Endometriosis Therapies Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Endometriosis Therapies Import and Export
5.4 Europe Endometriosis Therapies Market Analysis
5.4.1 Europe Endometriosis Therapies Production
5.4.2 Europe Endometriosis Therapies Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Endometriosis Therapies Import and Export
5.5 China Endometriosis Therapies Market Analysis
5.5.1 China Endometriosis Therapies Production
5.5.2 China Endometriosis Therapies Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Endometriosis Therapies Import and Export
5.6 Japan Endometriosis Therapies Market Analysis
5.6.1 Japan Endometriosis Therapies Production
5.6.2 Japan Endometriosis Therapies Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Endometriosis Therapies Import and Export
5.7 Southeast Asia Endometriosis Therapies Market Analysis
5.7.1 Southeast Asia Endometriosis Therapies Production
5.7.2 Southeast Asia Endometriosis Therapies Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Endometriosis Therapies Import and Export
5.8 India Endometriosis Therapies Market Analysis
5.8.1 India Endometriosis Therapies Production
5.8.2 India Endometriosis Therapies Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Endometriosis Therapies Import and Export
6 Endometriosis Therapies Segment Market Analysis (by Type)
6.1 Global Endometriosis Therapies Production by Type
6.2 Global Endometriosis Therapies Revenue by Type
6.3 Endometriosis Therapies Price by Type
7 Endometriosis Therapies Segment Market Analysis (by Application)
7.1 Global Endometriosis Therapies Consumption by Application
7.2 Global Endometriosis Therapies Consumption Market Share by Application (2014-2019)
8 Endometriosis Therapies Major Manufacturers Analysis
8.1 AbbVie
8.1.1 AbbVie Endometriosis Therapies Production Sites and Area Served
8.1.2 AbbVie Product Introduction, Application and Specification
8.1.3 AbbVie Endometriosis Therapies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Eli Lilly
8.2.1 Eli Lilly Endometriosis Therapies Production Sites and Area Served
8.2.2 Eli Lilly Product Introduction, Application and Specification
8.2.3 Eli Lilly Endometriosis Therapies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 AstraZeneca
8.3.1 AstraZeneca Endometriosis Therapies Production Sites and Area Served
8.3.2 AstraZeneca Product Introduction, Application and Specification
8.3.3 AstraZeneca Endometriosis Therapies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Bayer
8.4.1 Bayer Endometriosis Therapies Production Sites and Area Served
8.4.2 Bayer Product Introduction, Application and Specification
8.4.3 Bayer Endometriosis Therapies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Astellas Pharma
8.5.1 Astellas Pharma Endometriosis Therapies Production Sites and Area Served
8.5.2 Astellas Pharma Product Introduction, Application and Specification
8.5.3 Astellas Pharma Endometriosis Therapies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Meditrina Pharmaceuticals
8.6.1 Meditrina Pharmaceuticals Endometriosis Therapies Production Sites and Area Served
8.6.2 Meditrina Pharmaceuticals Product Introduction, Application and Specification
8.6.3 Meditrina Pharmaceuticals Endometriosis Therapies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Pfizer
8.7.1 Pfizer Endometriosis Therapies Production Sites and Area Served
8.7.2 Pfizer Product Introduction, Application and Specification
8.7.3 Pfizer Endometriosis Therapies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Neurocrine Biosciences
8.8.1 Neurocrine Biosciences Endometriosis Therapies Production Sites and Area Served
8.8.2 Neurocrine Biosciences Product Introduction, Application and Specification
8.8.3 Neurocrine Biosciences Endometriosis Therapies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Takeda Pharmaceutical
8.9.1 Takeda Pharmaceutical Endometriosis Therapies Production Sites and Area Served
8.9.2 Takeda Pharmaceutical Product Introduction, Application and Specification
8.9.3 Takeda Pharmaceutical Endometriosis Therapies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
9 Development Trend of Analysis of Endometriosis Therapies Market
9.1 Global Endometriosis Therapies Market Trend Analysis
9.1.1 Global Endometriosis Therapies Market Size (Volume and Value) Forecast 2019-2025
9.2 Endometriosis Therapies Regional Market Trend
9.2.1 North America Endometriosis Therapies Forecast 2019-2025
9.2.2 Europe Endometriosis Therapies Forecast 2019-2025
9.2.3 China Endometriosis Therapies Forecast 2019-2025
9.2.4 Japan Endometriosis Therapies Forecast 2019-2025
9.2.5 Southeast Asia Endometriosis Therapies Forecast 2019-2025
9.2.6 India Endometriosis Therapies Forecast 2019-2025
9.3 Endometriosis Therapies Market Trend (Product Type)
9.4 Endometriosis Therapies Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Endometriosis Therapies Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
Executive Summary
1 Industry Overview of Endometriosis Therapies
1.1 Definition of Endometriosis Therapies
1.2 Endometriosis Therapies Segment by Type
1.2.1 Global Endometriosis Therapies Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Hormonal Contraceptives
1.2.3 Gonadotropin-releasing Hormone (Gn-RH) Agonists
1.2.4 Progestin Therapy
1.2.5 Aromatase Inhibitors
1.3 Endometriosis Therapies Segment by Applications
1.3.1 Global Endometriosis Therapies Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Endometriosis Therapies Overall Market
1.4.1 Global Endometriosis Therapies Revenue (2014-2025)
1.4.2 Global Endometriosis Therapies Production (2014-2025)
1.4.3 North America Endometriosis Therapies Status and Prospect (2014-2025)
1.4.4 Europe Endometriosis Therapies Status and Prospect (2014-2025)
1.4.5 China Endometriosis Therapies Status and Prospect (2014-2025)
1.4.6 Japan Endometriosis Therapies Status and Prospect (2014-2025)
1.4.7 Southeast Asia Endometriosis Therapies Status and Prospect (2014-2025)
1.4.8 India Endometriosis Therapies Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Endometriosis Therapies
2.3 Manufacturing Process Analysis of Endometriosis Therapies
2.4 Industry Chain Structure of Endometriosis Therapies
3 Development and Manufacturing Plants Analysis of Endometriosis Therapies
3.1 Capacity and Commercial Production Date
3.2 Global Endometriosis Therapies Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Endometriosis Therapies
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Endometriosis Therapies Production and Capacity Analysis
4.2 Endometriosis Therapies Revenue Analysis
4.3 Endometriosis Therapies Price Analysis
4.4 Market Concentration Degree
5 Endometriosis Therapies Regional Market Analysis
5.1 Endometriosis Therapies Production by Regions
5.1.1 Global Endometriosis Therapies Production by Regions
5.1.2 Global Endometriosis Therapies Revenue by Regions
5.2 Endometriosis Therapies Consumption by Regions
5.3 North America Endometriosis Therapies Market Analysis
5.3.1 North America Endometriosis Therapies Production
5.3.2 North America Endometriosis Therapies Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Endometriosis Therapies Import and Export
5.4 Europe Endometriosis Therapies Market Analysis
5.4.1 Europe Endometriosis Therapies Production
5.4.2 Europe Endometriosis Therapies Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Endometriosis Therapies Import and Export
5.5 China Endometriosis Therapies Market Analysis
5.5.1 China Endometriosis Therapies Production
5.5.2 China Endometriosis Therapies Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Endometriosis Therapies Import and Export
5.6 Japan Endometriosis Therapies Market Analysis
5.6.1 Japan Endometriosis Therapies Production
5.6.2 Japan Endometriosis Therapies Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Endometriosis Therapies Import and Export
5.7 Southeast Asia Endometriosis Therapies Market Analysis
5.7.1 Southeast Asia Endometriosis Therapies Production
5.7.2 Southeast Asia Endometriosis Therapies Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Endometriosis Therapies Import and Export
5.8 India Endometriosis Therapies Market Analysis
5.8.1 India Endometriosis Therapies Production
5.8.2 India Endometriosis Therapies Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Endometriosis Therapies Import and Export
6 Endometriosis Therapies Segment Market Analysis (by Type)
6.1 Global Endometriosis Therapies Production by Type
6.2 Global Endometriosis Therapies Revenue by Type
6.3 Endometriosis Therapies Price by Type
7 Endometriosis Therapies Segment Market Analysis (by Application)
7.1 Global Endometriosis Therapies Consumption by Application
7.2 Global Endometriosis Therapies Consumption Market Share by Application (2014-2019)
8 Endometriosis Therapies Major Manufacturers Analysis
8.1 AbbVie
8.1.1 AbbVie Endometriosis Therapies Production Sites and Area Served
8.1.2 AbbVie Product Introduction, Application and Specification
8.1.3 AbbVie Endometriosis Therapies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Eli Lilly
8.2.1 Eli Lilly Endometriosis Therapies Production Sites and Area Served
8.2.2 Eli Lilly Product Introduction, Application and Specification
8.2.3 Eli Lilly Endometriosis Therapies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 AstraZeneca
8.3.1 AstraZeneca Endometriosis Therapies Production Sites and Area Served
8.3.2 AstraZeneca Product Introduction, Application and Specification
8.3.3 AstraZeneca Endometriosis Therapies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Bayer
8.4.1 Bayer Endometriosis Therapies Production Sites and Area Served
8.4.2 Bayer Product Introduction, Application and Specification
8.4.3 Bayer Endometriosis Therapies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Astellas Pharma
8.5.1 Astellas Pharma Endometriosis Therapies Production Sites and Area Served
8.5.2 Astellas Pharma Product Introduction, Application and Specification
8.5.3 Astellas Pharma Endometriosis Therapies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Meditrina Pharmaceuticals
8.6.1 Meditrina Pharmaceuticals Endometriosis Therapies Production Sites and Area Served
8.6.2 Meditrina Pharmaceuticals Product Introduction, Application and Specification
8.6.3 Meditrina Pharmaceuticals Endometriosis Therapies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Pfizer
8.7.1 Pfizer Endometriosis Therapies Production Sites and Area Served
8.7.2 Pfizer Product Introduction, Application and Specification
8.7.3 Pfizer Endometriosis Therapies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Neurocrine Biosciences
8.8.1 Neurocrine Biosciences Endometriosis Therapies Production Sites and Area Served
8.8.2 Neurocrine Biosciences Product Introduction, Application and Specification
8.8.3 Neurocrine Biosciences Endometriosis Therapies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Takeda Pharmaceutical
8.9.1 Takeda Pharmaceutical Endometriosis Therapies Production Sites and Area Served
8.9.2 Takeda Pharmaceutical Product Introduction, Application and Specification
8.9.3 Takeda Pharmaceutical Endometriosis Therapies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
9 Development Trend of Analysis of Endometriosis Therapies Market
9.1 Global Endometriosis Therapies Market Trend Analysis
9.1.1 Global Endometriosis Therapies Market Size (Volume and Value) Forecast 2019-2025
9.2 Endometriosis Therapies Regional Market Trend
9.2.1 North America Endometriosis Therapies Forecast 2019-2025
9.2.2 Europe Endometriosis Therapies Forecast 2019-2025
9.2.3 China Endometriosis Therapies Forecast 2019-2025
9.2.4 Japan Endometriosis Therapies Forecast 2019-2025
9.2.5 Southeast Asia Endometriosis Therapies Forecast 2019-2025
9.2.6 India Endometriosis Therapies Forecast 2019-2025
9.3 Endometriosis Therapies Market Trend (Product Type)
9.4 Endometriosis Therapies Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Endometriosis Therapies Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
